| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/15/2004 | WO2004031392A1 Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis |
| 04/15/2004 | WO2004031384A1 Mouse-origin proteins forming domain or use thereof |
| 04/15/2004 | WO2004031382A1 Novel method of constructing monoclonal antibody |
| 04/15/2004 | WO2004031362A2 Multimeric protein engineering |
| 04/15/2004 | WO2004031354A2 Human sarcoma-associated antigens |
| 04/15/2004 | WO2004031241A1 Monoclonal antibody against subtilisin-like proprotein convertase pace4 and utilization thereof |
| 04/15/2004 | WO2004031240A1 Monoclonal antibody anti-c3-2 directed against the third component of complement (c3) and its use in methods to inhibit complement activation |
| 04/15/2004 | WO2004031239A2 Metastasis inducing compounds |
| 04/15/2004 | WO2004031238A2 Antibodies and cyclic peptides which bind cea (carcinoembryonic antigen) and their use as cancer therapeutics |
| 04/15/2004 | WO2004031230A2 Novel mhc ii associated peptides |
| 04/15/2004 | WO2004031209A2 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 04/15/2004 | WO2004031206A2 Products for regulating the degradation of collagen and methods for indentifying same |
| 04/15/2004 | WO2004031105A2 Use of a33 antigens and jam-it |
| 04/15/2004 | WO2004030699A1 Use of molecules which interact with the haptoglobin receptor ligand binding |
| 04/15/2004 | WO2004030698A1 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 04/15/2004 | WO2004030697A1 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer |
| 04/15/2004 | WO2004030695A1 Treatment of vascular diseases |
| 04/15/2004 | WO2004030610A2 Compositions and methods for the intracellular delivery of antibodies |
| 04/15/2004 | WO2004030607A2 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 04/15/2004 | WO2004030522A2 Diagnosis and monitoring of diseases |
| 04/15/2004 | WO2004030448A1 RELATIONSHIP BETWEEN LIPOPROTEIN (a) AND ATHEROMA SCLEROSIS |
| 04/15/2004 | WO2004004451B1 Methods of screening compounds for grk6 modulating activity |
| 04/15/2004 | WO2003104803A3 Method for mapping and eliminating t-cell epitopes |
| 04/15/2004 | WO2003070752A3 Mhc-peptide complex binding ligands |
| 04/15/2004 | WO2003068151A3 Human antibodies for therapy against vaccinia or smallpox |
| 04/15/2004 | WO2003059951A3 Novel anti-igf-ir antibodies and uses thereof |
| 04/15/2004 | WO2003020767A9 Antibodies against caspase-8, their preparation and use |
| 04/15/2004 | WO2003019142A3 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque |
| 04/15/2004 | WO2003006057A8 Composition and method for the treatment of disease |
| 04/15/2004 | WO2003002722A9 T cell regulatory genes and methods of use thereof |
| 04/15/2004 | WO2002102975A3 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans |
| 04/15/2004 | WO2002081703A9 Mitogenic oxygenase regulators |
| 04/15/2004 | WO2002064763A8 Novel human poly(a)polymerase gamma (pap gamma) |
| 04/15/2004 | WO2002055706A3 Asip-related proteins |
| 04/15/2004 | WO2001070955A8 Identification of essential genes in prokaryotes |
| 04/15/2004 | US20040073957 Isolation of a rearranged human immunoglobulin gene from a chimeric mouse and recombinant production of the encoded immunoglobulin |
| 04/15/2004 | US20040073013 Polypeptide inducing apoptosis |
| 04/15/2004 | US20040073012 Monoclonal antibody for diagnosis and treatment of glomerulonephritis, autoimmune and allergic diseases |
| 04/15/2004 | US20040073011 Specific human antibodies for selective cancer therapy |
| 04/15/2004 | US20040073006 Antibody against norwalk virus and method of detecting virus by using the antibody |
| 04/15/2004 | US20040073004 Comprises Ajuba like protein for diagnosis, prevention and treatment of cell proliferative, cardiovascular and neurodegenerative disease |
| 04/15/2004 | US20040073003 Neuromedin u delta |
| 04/15/2004 | US20040073000 Genes and proteins, and their uses |
| 04/15/2004 | US20040072999 Novel protein inhibitor of apoptosis proteins |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072993 Identifying modulator of chimeric chaperone protein for treatment and diagnosis of immune, cell proliferative and infectious disorders |
| 04/15/2004 | US20040072773 Novel functions for dp214 |
| 04/15/2004 | US20040072772 Survival Regulating Kinase, SRK, involved in cell signal transduction; method of detecting a protein kinase activity in a human SRK polypeptide |
| 04/15/2004 | US20040072759 Polypeptides |
| 04/15/2004 | US20040072749 Composition for the elimination of autoreactive b-cells |
| 04/15/2004 | US20040072748 Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
| 04/15/2004 | US20040072747 Novel member of the epha receptor family |
| 04/15/2004 | US20040072740 Directed evolution of enzymes and antibodies |
| 04/15/2004 | US20040072302 High throughput production of antibodies to genomic derived proteins |
| 04/15/2004 | US20040072299 Multiple cytokine protein complexes |
| 04/15/2004 | US20040072297 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives |
| 04/15/2004 | US20040072291 Comprises genetically engineered nerve growth factor for diagnosis and treatment of nervous system and neurodegenerative disease |
| 04/15/2004 | US20040072290 Transgenic cells expressing anti-human squamous-cell carcinoma monoclonal antibody with enhanced antibody dependent cellular cytotoxicity (ADCC); drug targeting and delivery |
| 04/15/2004 | US20040072271 Using recombinantly derived antibodies (rVab) to identify unique active surfaces of pharmaceutical targets |
| 04/15/2004 | US20040072267 Method for simultaneously detecting an antigen of, and and antibody against, an infectious microorganism |
| 04/15/2004 | US20040072256 Nk cells activiating receptors and their therapeutic and diagnostic uses |
| 04/15/2004 | US20040072253 Novel protein and DNA thereof |
| 04/15/2004 | US20040072241 Detecting anti-bacillus antibody in biological samples; biological and chemical warfare agents |
| 04/15/2004 | US20040072238 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 04/15/2004 | US20040072233 Multihue labels |
| 04/15/2004 | US20040072229 Comprises nucleotide sequences coding ligand binding membrane protein for identifying modulator for treatment of kidney, neural, pancreatic or prostate diseases |
| 04/15/2004 | US20040072220 Neurotonin and use thereof |
| 04/15/2004 | US20040072219 Genetically engineered obesity protein with reduced immune response for treatment of diabetes, high blood pressure and cholesterol metabolism disorders |
| 04/15/2004 | US20040072214 Novel glycoproteins and methods of use thereof |
| 04/15/2004 | US20040072196 Novel serpentine transmembrane antigens expressed in human cancers and uses therefor |
| 04/15/2004 | US20040072189 Diagnosing cancer via presence of osteopontin in epithelial cells; genetic vaccines; antitumor agents |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040072185 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses |
| 04/15/2004 | US20040072177 Novel human serine-threonine kinase |
| 04/15/2004 | US20040072174 Calpain protease 12 |
| 04/15/2004 | US20040072172 Comprises enzymatic polypeptide associated with calcium dependent movement of phospholipids through plasmid membranes for diagnosis and treatment of thrombosis, angina pectoris and stroke; gene therapy |
| 04/15/2004 | US20040072171 Screening for regulatory factors of neurofibromatosis (NF2); antitumor agents |
| 04/15/2004 | US20040072169 Comprises nucleotide sequences coding polypeptide for exogenous expression in avian embryonic stem cells; bioreactors |
| 04/15/2004 | US20040072159 Bzip type transcription factors regulating the expression of rice storage protein |
| 04/15/2004 | US20040072154 Novel compositions and methods for cancer |
| 04/15/2004 | US20040071787 Pharmacologic, therapeutic and diagnostic regulation of FGF-1 export |
| 04/15/2004 | US20040071725 Administered with target antigens to treat infections; anticarcinogenic and antitumor agents; genetic engineering |
| 04/15/2004 | US20040071724 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071721 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071720 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071714 A gene expressed polypeptide is used in food, for treating food allergy |
| 04/15/2004 | US20040071713 A protein is obtained from gene expression of Pseudomonas aeruginosa, molecular weight range from 13 kDa to 80 kDa, purification, antibody, immunization with vaccine antigens, treating bacterial infections |
| 04/15/2004 | US20040071712 Modified peptides as therapeutic agents |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |
| 04/15/2004 | US20040071710 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/15/2004 | US20040071707 Modulation of cell growth |
| 04/15/2004 | US20040071706 An antibody for treating Crohn's disease and ulcerative colitis, inhibit the transduction of biological activity of cytokine, B-cell differentiation factors |
| 04/15/2004 | US20040071705 Serum protein-associated target-specific ligands and identification method therefor |
| 04/15/2004 | US20040071704 Antithrombotic von willebrand factor (vwf) collagen bridging blockers |
| 04/15/2004 | US20040071702 Homologous recombination, heavy chain peptides, amino acid sequences, light chain peptides, for treating inflammatory disorders, rheumatoid arthritis, psoriasis, transplant rejections and cancers |
| 04/15/2004 | US20040071701 Nerve growth factor antagonist for treating pain caused by physiological disorder, no side effects |
| 04/15/2004 | US20040071699 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 04/15/2004 | US20040071698 Human anti-epidermal growth factor receptor single-chain antibodies |
| 04/15/2004 | US20040071697 Reducing epithelial toxicity during cancer therapy |
| 04/15/2004 | US20040071696 Bispecific single chain Fv antibody molecules and methods of use thereof |